HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Warns Another 'Stem Cell' Skin-Care Marketer For Overreaching Claims

This article was originally published in The Rose Sheet

Executive Summary

Stem cell-related claims on cosmetics may capture consumers' imagination, but they seem to be grabbing FDA's attention as well. Hollywood Skincare International, which markets its DermaSet Stem Cell 3D Renewal cream online through a negative billing option, is the latest player in this game to receive a warning letter from the agency.


Related Content

FDA Warning Cites Ageless Derma's Anti-Wrinkle, Brightening Claims
Cosmetics E-tailers At Risk Amid Trending Auto-Renewal Class Actions
‘Revolution’ Quelled? FDA Warns Firm For ReLuma Stem-Cell Claims





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts